Epstein Secrets

s Microsoft turbocharges the =rocess — in place for several years now — to select its next leader.</=pan> But, though the committee is headed up by John Thompson, CEO of Virtua= Instruments and the former CEO of security software giant Symantec, most expect Gates — as usual — to be the key decision maker =n t

44532 EFTA02574066 "People are shocked whe= they hear that a bag of saline solution costs far less than their cup of =offee in the morning," said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that ma=e nearly all the IV solutions used in the United State

ot now as Microsoft turbocharges the process — in place for several years now — to select its next leader. But, though the committee is headed up by John Thompson, CEO of Virtual Instruments and the former CEO of security software giant Symantec, most expect Gates — as usual — to be the key decision maker on th

ted States each year. “People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning,” said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States

oot now as Microsoft turbocharges the process — in place for several years now — to select its next leader. But, though the committee is headed up by John Thompson, CEO of Virtual Instruments and the former CEO of security software giant Symantec, most expect Gates — as usual — to be the key decision maker on th

ited States each year. "People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning," said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States